Flow Traders U.S.’s Idexx Laboratories IDXX Stock Holding History

Flow Traders U.S.’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-128	Closed	-$8K	–	205
2014 Q3	$8K	Buy	+128	New	+$8.09K	﹤0.01%	156

Other funds holding IDXX

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flow Traders U.S.'s IDXX Position: Q4 2014 in Review

Flow Traders U.S. sold out of Idexx Laboratories (IDXX) in Q4 2014, closing a stake of 128 shares — an estimated $8K sold.

Flow Traders U.S. first reported a position in IDXX in Q3 2014 and held it in 1 quarter. The position peaked at $8K in Q3 2014. 352 funds tracked by Wall St. Rank hold IDXX as of Q4 2014.

Flow Traders U.S. reported no remaining Idexx Laboratories position as of Q4 2014 after selling out during the quarter.
Flow Traders U.S. sold 128 Idexx Laboratories shares in Q4 2014, an estimated $8K.
Flow Traders U.S. first reported a position in Idexx Laboratories in Q3 2014 and held it in 1 quarter.
Flow Traders U.S.'s Idexx Laboratories position peaked at $8K in Q3 2014.
352 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2014.

Based on Flow Traders U.S.'s 13F filing for Q4 2014, filed 10 Feb 2015.